Prestige Consumer Healthcare PBH
NYSE PBH
$51.31 +0.79 (+1.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

Prestige Consumer Healthcare (PBH) Asset Writedowns and Impairment (2018 - 2023)

Prestige Consumer Healthcare (PBH) posted quarterly Asset Writedowns and Impairment of $369.8 million for Q1 2023, up 34882.97% year-over-year from N/an in Q1 2022, and up 36976900.0% quarter-over-quarter from $1000.0 in Q3 2022.

Prestige Consumer Healthcare (PBH) Asset Writedowns and Impairment (2018 - 2023) Analysis & Trends

Prestige Consumer Healthcare's Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $369.8 million for Q1 2023.

  • In Q1 2023, Asset Writedowns and Impairment rose 34882.97% year-over-year to $369.8 million; the TTM figure through Sep 2023 stood at $369.8 million (up 24485.77% YoY), while the FY2025 annual figure was $12.5 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment for Q1 2023 stood at $369.8 million, up from $1000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $369.8 million in Q1 2023, with the low at -$34000.0 in Q1 2020.
  • The 5-year median for Asset Writedowns and Impairment is $446000.0 (2022), against an average of $54.8 million.
  • The sharpest annual moves came in 2020 and 2023: Asset Writedowns and Impairment plunged 100.01% in 2020, then soared 34882.97% in 2023.
  • Prestige Consumer Healthcare's Asset Writedowns and Impairment stood at $34000.0 in 2019, then soared by 2335.29% to $828000.0 in 2020, then surged by 80.8% to $1.5 million in 2021, then sank by 99.93% to $1000.0 in 2022, then jumped by 36976900.0% to $369.8 million in 2023.
  • Business Quant data shows PBH's Asset Writedowns and Impairment at $369.8 million in Q1 2023, $1000.0 in Q3 2022, and $446000.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Prestige Consumer Healthcare 2.46 Bn 2.39 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2023 369.77 Mn
Mar 31, 2023 369.77 Mn
Sep 30, 2022 1,000.00
Sep 30, 2022 1,000.00
Jun 30, 2022 446,000.00
Jun 30, 2022 446,000.00
Mar 31, 2022 1.06 Mn
Mar 31, 2022 1.06 Mn
Mar 31, 2021 1.50 Mn
Mar 31, 2021 1.50 Mn
Dec 31, 2020 828,000.00
Dec 31, 2020 828,000.00
Sep 30, 2020 59,000.00
Sep 30, 2020 59,000.00
Jun 30, 2020 50,000.00
Jun 30, 2020 50,000.00
Mar 31, 2020 -34,000.00
Mar 31, 2020 -34,000.00
Dec 31, 2019 34,000.00
Dec 31, 2019 34,000.00